Managing Hyperkalemia in Heart Failure:
Overcoming Roadblocks with Best Practices

Registration for this program is now closed.

Program Overview:
Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy decreases cardiovascular morbidity and mortality in patients with heart failure (HF). Evidence-based HF guidelines support the titration of RAASi to achieve target doses to optimize treatment benefits. However, RAASi also increases the risk of hyperkalemia. Hyperkalemia is an electrolyte disorder characterized by elevated levels of serum potassium; if left untreated, hyperkalemia can lead to fatal cardiac arrhythmias, cardiac arrest, and sudden death. Hyperkalemia is a barrier to optimization of RAASi therapy in patients with HF; despite strong evidence for cardiorenal protective effects of RAASi, unfortunately down-titration or discontinuation of RAASi treatment is a common strategy to manage hyperkalemia in routine clinical practice; these actions place HF patients at increased risk of major adverse clinical events. Novel potassium binders effectively and safely lower serum potassium, potentially enabling HF patients to remain on optimal RAASi therapy. Therefore, in this educational initiative, a faculty of experts — cardiologists Dr. Mikhail Kosiborod, Dr. Mark Petrie, and Dr. Shelley Zieroth, and nephrologist Dr. David Cherney — will explain, through lecture and "real-world " case presentation, best practices for managing hyperkalemia with potassium binders and facilitating maintenance of cardiorenal protection with RAASi.

Educational Objectives: 
Upon completion of this activity, participants should be able to:

Accreditation & Credit Designation:
Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 1.5 AMA PRA Category Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits ™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits ™ from organizations accredited by the ACCME.

Educational Grant:
Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

Disclosure Statement:
Voxmedia strives to ensure fair-balance, independence, objectivity, and scientific rigor in all directly or jointly sponsored educational activities. All prospective faculty are required to disclose to Voxmedia all financial relationships for the preceding 24 months (1) with any commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients AND (2) with any commercial supporters prior to participating in the planning of an activity or developing content. Only after Voxmedia mitigates all financial relationships may faculty receive approval to participate, and are expected to contribute evidence-based material. Faculty are required to indicate areas of their presentation that are based on professional opinion vs. guidelines, meta-analysis. All information submitted will be peer-reviewed. The intent of this disclosure is not to prevent faculty from participating, but rather to provide learners with information on which they can make their own judgment of commercial bias. Voxmedia will disclose to learners that all relevant financial relationships have been mitigated in either written materials, visually and/or verbally. It remains for the audience to determine whether the speaker s interests or relationships may influence the presentation. Speakers must make a meaningful disclosure to the audience of their discussions of any unlabeled or investigational use(s) of drugs or devices.

Random-Drawing Contest Rules and Regulations*
1. Drawing is open to all licensed medical professionals 18 years of age and older who are legal residents of the United States and who attend to-the-end Voxmedia’s CME Symposium ‘Managing Hyperkalemia in Heart Failure: Overcoming Roadblocks with Best Practices’ (“CME Symposium”) on November 17, 2024 at the Hyatt Regency McCormick Place, 2233 S. Dr. Martin Luther King Jr. Drive, Chicago, Illinois. Drawing is promoted by Voxmedia LLC dba CMEPlanet.com, 1 Bethany Road, Hazlet, NJ 07730.

2. NO PURCHASE NECESSARY. To be entered into the drawing, you must check-in on-site for the CME Symposium prior to 6:00 PM on November 17, 2024, and be present at time of drawing approx. 7:45 PM on November 17, 2024.

3. Four (4) total prizes will be awarded in the form of $150.00 Amazon Gift Cards to four (4) randomly-selected winners. One prize per winner. Prize is non-transferable and non-assignable. No substitution of prizes is permitted except by Voxmedia. Prize is not redeemable for cash. The odds of winning are dependent upon the number of eligible entries received. Voxmedia reserves the right to require proof of medical license and jurisdiction of residence prior to awarding any prize. Voxmedia/ CMEPlanet.com reserves the right to use the winner’s name, practice/affiliation, city/state and photograph for publicity purposes without further permission or compensation. All federal, state, and local laws and regulations apply. Void where prohibited.